Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ)
CNY 14.75
(0.07%)
CNY 14.75
(0.07%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.11 Billion CNY | -2.82% |
| 2022 | 1.15 Billion CNY | -8.32% |
| 2021 | 1.25 Billion CNY | 36.04% |
| 2020 | 923.27 Million CNY | 53.83% |
| 2019 | 600.18 Million CNY | 0.12% |
| 2018 | 599.46 Million CNY | 4.14% |
| 2017 | 575.65 Million CNY | 29.58% |
| 2016 | 444.25 Million CNY | 6.64% |
| 2015 | 416.59 Million CNY | -10.04% |
| 2014 | 463.06 Million CNY | -4.74% |
| 2013 | 486.11 Million CNY | 19.36% |
| 2012 | 407.26 Million CNY | 86.67% |
| 2011 | 218.17 Million CNY | 20.23% |
| 2010 | 181.47 Million CNY | -34.96% |
| 2009 | 278.99 Million CNY | -26.32% |
| 2008 | 378.64 Million CNY | 8.32% |
| 2007 | 349.57 Million CNY | 70.96% |
| 2006 | 204.48 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 875.31 Million CNY | -2.59% |
| 2024 Q3 | 920.16 Million CNY | 5.12% |
| 2024 Q1 | 898.6 Million CNY | -19.7% |
| 2023 Q3 | 853.98 Million CNY | 5.43% |
| 2023 Q4 | 1.11 Billion CNY | 31.04% |
| 2023 Q1 | 1.12 Billion CNY | -1.96% |
| 2023 Q2 | 810.02 Million CNY | -28.26% |
| 2023 FY | 1.11 Billion CNY | -2.82% |
| 2022 FY | 1.15 Billion CNY | -8.32% |
| 2022 Q3 | 1.11 Billion CNY | -6.8% |
| 2022 Q2 | 1.19 Billion CNY | -1.44% |
| 2022 Q4 | 1.15 Billion CNY | 3.21% |
| 2022 Q1 | 1.21 Billion CNY | -3.29% |
| 2021 Q2 | 930.41 Million CNY | -1.03% |
| 2021 Q4 | 1.25 Billion CNY | 25.62% |
| 2021 FY | 1.25 Billion CNY | 36.04% |
| 2021 Q1 | 940.08 Million CNY | 1.82% |
| 2021 Q3 | 999.9 Million CNY | 7.47% |
| 2020 Q1 | 642.68 Million CNY | 7.08% |
| 2020 Q3 | 702.19 Million CNY | 4.4% |
| 2020 Q4 | 923.27 Million CNY | 31.48% |
| 2020 Q2 | 672.62 Million CNY | 4.66% |
| 2020 FY | 923.27 Million CNY | 53.83% |
| 2019 Q1 | 551.11 Million CNY | -8.07% |
| 2019 FY | 600.18 Million CNY | 0.12% |
| 2019 Q4 | 600.18 Million CNY | 15.82% |
| 2019 Q3 | 518.18 Million CNY | 7.35% |
| 2019 Q2 | 482.68 Million CNY | -12.42% |
| 2018 Q2 | 421.97 Million CNY | -21.56% |
| 2018 Q4 | 599.46 Million CNY | 31.67% |
| 2018 Q3 | 455.28 Million CNY | 7.89% |
| 2018 Q1 | 537.95 Million CNY | -6.55% |
| 2018 FY | 599.46 Million CNY | 4.14% |
| 2017 Q1 | 503.77 Million CNY | 13.4% |
| 2017 Q2 | 490.81 Million CNY | -2.57% |
| 2017 Q3 | 512.44 Million CNY | 4.41% |
| 2017 Q4 | 575.65 Million CNY | 12.34% |
| 2017 FY | 575.65 Million CNY | 29.58% |
| 2016 Q2 | 337.88 Million CNY | -16.5% |
| 2016 Q4 | 444.25 Million CNY | 25.52% |
| 2016 Q1 | 404.66 Million CNY | -2.86% |
| 2016 FY | 444.25 Million CNY | 6.64% |
| 2016 Q3 | 353.94 Million CNY | 4.75% |
| 2015 Q4 | 416.59 Million CNY | 26.49% |
| 2015 Q3 | 329.35 Million CNY | -6.25% |
| 2015 Q2 | 351.3 Million CNY | -12.36% |
| 2015 Q1 | 400.82 Million CNY | -13.44% |
| 2015 FY | 416.59 Million CNY | -10.04% |
| 2014 Q1 | 466.38 Million CNY | -4.06% |
| 2014 FY | 463.06 Million CNY | -4.74% |
| 2014 Q4 | 463.06 Million CNY | -7.68% |
| 2014 Q3 | 501.59 Million CNY | 17.87% |
| 2014 Q2 | 425.54 Million CNY | -8.76% |
| 2013 Q2 | 421.12 Million CNY | -4.42% |
| 2013 Q1 | 440.61 Million CNY | 8.19% |
| 2013 Q3 | 486.89 Million CNY | 15.62% |
| 2013 Q4 | 486.11 Million CNY | -0.16% |
| 2013 FY | 486.11 Million CNY | 19.36% |
| 2012 Q3 | 325.05 Million CNY | 8.42% |
| 2012 FY | 407.26 Million CNY | 86.67% |
| 2012 Q1 | 250.31 Million CNY | 14.73% |
| 2012 Q2 | 299.8 Million CNY | 19.77% |
| 2012 Q4 | 407.26 Million CNY | 25.29% |
| 2011 FY | 218.17 Million CNY | 20.23% |
| 2011 Q4 | 218.17 Million CNY | 18.83% |
| 2011 Q2 | 170.05 Million CNY | -20.3% |
| 2011 Q1 | 213.37 Million CNY | 17.58% |
| 2011 Q3 | 183.6 Million CNY | 7.97% |
| 2010 FY | 181.47 Million CNY | -34.96% |
| 2010 Q1 | 219.14 Million CNY | -21.45% |
| 2010 Q4 | 181.47 Million CNY | 55.08% |
| 2010 Q3 | 117.01 Million CNY | -30.77% |
| 2010 Q2 | 169.01 Million CNY | -22.88% |
| 2009 FY | 278.99 Million CNY | -26.32% |
| 2009 Q3 | 149.6 Million CNY | -50.81% |
| 2009 Q4 | 278.99 Million CNY | 86.49% |
| 2009 Q2 | 304.13 Million CNY | 0.0% |
| 2008 Q4 | 378.64 Million CNY | 0.0% |
| 2008 FY | 378.64 Million CNY | 8.32% |
| 2007 FY | 349.57 Million CNY | 70.96% |
| 2006 FY | 204.48 Million CNY | 0.0% |